David A. Siegel Kamada LTD Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Kamada LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 95,300 shares of KMDA stock, worth $669,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,300
Previous 73,200
30.19%
Holding current value
$669,959
Previous $567,000
16.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KMDA
# of Institutions
48Shares Held
5.96MCall Options Held
0Put Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.6 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny872KShares$6.13 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA606KShares$4.26 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA396KShares$2.79 Million0.48% of portfolio
-
Acadian Asset Management LLC Boston, MA274KShares$1.93 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $315M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...